Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd., explained in plain language.
-
New drug ASKB589 tested against advanced cancers
Disease control OngoingThis study tests an experimental drug called ASKB589 in about 199 people with advanced solid tumors that have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. People with stomach or pancreatic cancer are especially wanted for …
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:35 UTC
-
Can a lotion outperform standard gel for knee pain?
Symptom relief OngoingThis phase II trial is testing whether an experimental lotion called ASKC200 can reduce pain in people with knee osteoarthritis. About 175 adults aged 40 to 80 with knee pain lasting at least six months will be randomly assigned to receive one of two strengths of ASKC200, a stand…
Phase: PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC